Bladder Cancer Breakthrough: TAR-200 Shines

Did you see this? TAR-200, a new drug-releasing system, is showing some seriously impressive results for people with high-risk bladder cancer who didn’t respond to BCG. In the latest trial, over 80% of patients stayed disease-free at 9 months, and hardly anyone needed their bladder removed. Side effects were mostly mild and cleared up fast. There’s even a new FDA application in the works—this could be a total game-changer for bladder cancer treatment! #BladderCancer #MedicalBreakthrough #CancerResearch #TAR200 #HealthNews #Health